Clinical Study to Evaluate the Safety and Efficacy of a Unani Formulation in the Management of Mutal ?zima Mabya ?-i-Muta‘ddad al-Kis ?t (Polycystic Ovarian Syndrome)
Phase 2
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2024/03/064942
- Lead Sponsor
- ATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS HYDERABAD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants of PCOS as diagnosed by Rotterdam Criteria
Clinical Hyperandrogenism
or
Biochemical Hyperandrogenism (Raised Testosterone)
Evidence of Oligo-anovulation
Oligo-amenorrhea
Amenorrhea
Polycystic Ovarian Morphology (PCOM) on USG
or
BMI
Exclusion Criteria
Patients having congenital uterine abnormalities
Patients with history of Hormone Replacement Therapy, or using any other long-term medication
Patients with known active systemic diseases
Known Cases of Hypothyroidism, severe Hyperprolactinemia Diabetes Mellitus and other immunocompromised disorders
Pregnant or Lactating women
Participants not willing to give consent and to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method